[Estrogen treatment only when symptoms are present but complaints should not be neglected]
- PMID: 866107
[Estrogen treatment only when symptoms are present but complaints should not be neglected]
Abstract
PIP: The use of estrogen during the climacterium is discussed. Estrogen should be used only when objective symptoms of a lack of estrogen can be established. Thrombosis, hypertension, breast cancer, uterine cancer and ruptured blood vessels are contraindications to climacteric estrogen use. Progestagens administered in conjunction with sedatives and diuretics can often relieve climacteric afflictions. Continued administration of estrogen should be avoided; estrogen can be administered with or without gestagens 7-10 days before menstruation or in 21-day periods. General practitioners are qualified to administer estrogen and should give patients regular examinations. There is a risk of developing endometrial cancer under climacteric estrogen treatment. Only women who want and need climacteric estrogen treatment should receive it.
Similar articles
-
[Hormone treatment in estrogen deficiency can be as natural as insulin in diabetes].Nord Med. 1977 May;92(5):154-5. Nord Med. 1977. PMID: 866108 Swedish.
-
[Peroral treatment with natural human estrogens in the climacteric].Ugeskr Laeger. 1980 Sep 15;142(38):2497-500. Ugeskr Laeger. 1980. PMID: 7445154 Danish.
-
[From the Adverse Drug Reaction Committee. Can long-term estrogen treatment induce uterine neoplasms in post-climacteric women?].Tidsskr Nor Laegeforen. 1976 Mar 30;96(9-10):594-5. Tidsskr Nor Laegeforen. 1976. PMID: 1258036 Norwegian.
-
Estrogen therapy of perimenopausal and postmenopausal patients.Am J Hosp Pharm. 1979 Aug;36(8):1062-71. Am J Hosp Pharm. 1979. PMID: 384786 Review. No abstract available.
-
Estrogen replacement therapy.Obstet Gynecol. 1981 Sep;58(3):267-75. Obstet Gynecol. 1981. PMID: 7022279 Review.